FDA rejects Genzyme's MS drug Lemtrada

The U.S. Food and Drug Administration has rejected Genzyme's multiple sclerosis therapy Lemtrada over concerns about safety risks and trial design...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.